PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026

PolyPid (Nasdaq: PYPD) will report first quarter 2026 financial results and operational highlights before U.S. markets open on Wednesday, May 13, 2026.

Rhea-AI Summary

PolyPid (Nasdaq: PYPD) will report first quarter 2026 financial results and operational highlights before U.S. markets open on Wednesday, May 13, 2026.

The company will host a conference call and webcast at 8:30 AM Eastern Time. Registration is recommended at least 5 minutes before the call; a webcast option is available for listeners.

Argus May 6 session

-0.44% close to close Open Argus

Details

News Market Reaction – PYPD

In the May 6 session, PYPD declined 0.44%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the date and time for PolyPid’s first quarter 2026 results on May 13, continu...

Analysis

This announcement sets the date and time for PolyPid’s first quarter 2026 results on May 13, continuing its pattern of pre-announcing earnings calls. The update is procedural, outlining an 8:30 AM ET conference call and webcast for operational commentary. In context of recent NDA and Phase 3 developments, investors may focus on how the upcoming call frames funding needs, commercialization plans, and timelines for D-PLEX100 and related programs.

Key Figures

Earnings release date: May 13, 2026 Conference call time: 8:30 AM Eastern Time Suggested early registration: 5 minutes

Earnings release date

May 13, 2026

First quarter 2026 financial results announcement before U.S. market open

Conference call time

8:30 AM Eastern Time

Management call to discuss Q1 2026 financial results and operations

Suggested early registration

5 minutes

Recommended lead time before start of the conference call

Previous Earnings date Reports

1 past event · Latest: Jan 28

Same Type 1 event

1. Jan 28

   Earnings date set

   24h Move

   -1.7%

   Announced Q4 2025 earnings call date and reiterated D-PLEX100 NDA timing.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PETACH TIKVA, Israel, May 06, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today announced that it will report its first quarter 2026 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, May 13, 2026. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.

To ensure you are connected prior to the beginning of the call, PolyPid suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of management, the Company recommends listening via the webcast.

Conference Call Dial-In & Webcast Information:

Date:	Wednesday, May 13, 2026
Time:	8:30 AM Eastern Time
Conference Call:	https://register-conf.media-server.com/register/BI510ef0c33b114b5b87c2bd9d3c34e882
Webcast:	https://edge.media-server.com/mmc/p/w3mvdb4o

About PolyPid
PolyPid Ltd. (Nasdaq: PYPD) is an innovative biopharmaceutical company dedicated to elevating treatment effectiveness, right where care begins. The Company develops long-acting, controlled-release drugs designed to deliver therapy precisely at the site of care, addressing critical unmet medical needs across a wide and diverse pipeline spanning surgical care, metabolic diseases, and beyond. PolyPid’s lead product, D-PLEX₁₀₀, successfully met its primary and all key secondary endpoints in the landmark Phase 3 SHIELD II trial for the prevention of surgical site infections. Guided by a commitment to precision and innovation, PolyPid is redefining how therapies perform and raise the standard of patient care. For additional Company information, please visit http://www.polypid.com and follow us on Twitter (X) and LinkedIn.

Company Contact:
PolyPid Ltd.
Ori Warshavsky
908-858-5995
IR@Polypid.com

Investor Relations Contact:
Arx Investor Relations
North American Equities Desk
polypid@arxhq.com

FAQ

When will PolyPid (PYPD) release Q1 2026 results and how can I listen?

PolyPid will release Q1 2026 results before U.S. markets open on May 13, 2026. According to the company, a conference call and live webcast start at 8:30 AM Eastern Time and registration links are provided for call access and webcast listening.

What time is the PolyPid (PYPD) earnings call on May 13, 2026?

The PolyPid earnings call is scheduled for 8:30 AM Eastern Time on May 13, 2026. According to the company, investors should register at least five minutes before the call; a webcast link is available for those not asking questions.

Where can I register for PolyPid (PYPD) May 13, 2026 conference call?

Register using the conference call registration link provided by the company prior to the event. According to the company, the registration page and a separate webcast URL are published for live access and participation.

Should investors use the webcast or dial-in for PolyPid (PYPD) Q1 2026 remarks?

Investors not asking questions are recommended to use the webcast, while callers can use the dial-in after registering. According to the company, the webcast provides full audio access and the conference call supports question-and-answer participation.